Showing results (91-100 of 359) with videos related to

Sort By:
Pageof 36
Radiation Research|May 14, 2026
Factors Influencing Double-Strand Break Focus Biodosimetry for Detection of Internal Low-LET Irradiation in Human Blood SamplesIsabella Strobel, Harry Scherthan, Karina Blaurock, et al.
Clinical Nuclear Medicine|September 5, 2018
Chemokine Receptor 4 Expression in Primary Sjögren's SyndromeWojciech Cytawa, Stefan Kircher, Andreas Schirbel, et al.
EJNMMI Research|May 16, 2015
Influence of the amount of co-infused amino acids on post-therapeutic potassium levels in peptide receptor radionuclide therapyConstantin Lapa, Rudolf A Werner, Christina Bluemel, et al.
International Journal of Molecular Sciences|May 25, 2024
Modelling the In Vivo and Ex Vivo DNA Damage Response after Internal Irradiation of Blood from Patients with Thyroid CancerSarah Schumann, Harry Scherthan, Philipp E Hartrampf, et al.
Methods (San Diego, Calif.)|September 17, 2017
Chemokine receptor - Directed imaging and therapyAndreas K Buck, Antje Stolzenburg, Heribert Hänscheid, et al.
Molecular Imaging and Biology|January 4, 2024
Evaluating the Patterns of FAPI Uptake in the Shoulder Joint: a Preliminary Study Comparing with FDG Uptake in Oncological StudiesYohji Matsusaka, Rudolf A Werner, Sebastian E Serfling, et al.
Nuclear Medicine and Biology|March 27, 2007
Synthesis and biodistribution of 3'-fluoro-5-[(131)I]iodo-2'-deoxyuridine: a comparative study of [(131)I]FLIdU and [(18)F]FLTAndreas T J Vogg, Andreas K Buck, Michaela Schmid, et al.
Annals of Nuclear Medicine|August 15, 2018
CXCR4-directed theranostics in oncology and inflammationMalte Kircher, Peter Herhaus, Margret Schottelius, et al.
Clinical Nuclear Medicine|March 17, 2023
Partial Response Upon Peptide Receptor Radionuclide Therapy in a Highly Proliferative Pancreatic Neuroendocrine TumorAlexander Weich, Sebastian E Serfling, Steven P Rowe, et al.
Pageof 36